These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 10854579

  • 1. Opposite effects of glutamate antagonists and antiparkinsonian drugs on the activities of DOPA decarboxylase and 5-HTP decarboxylase in the rat brain.
    Fisher A, Starr MS.
    Brain Res; 2000 Jun 23; 868(2):268-74. PubMed ID: 10854579
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of NMDA and non-NMDA antagonists on the activity of aromatic L-amino acid decarboxylase activity in the nigrostriatal dopamine pathway of the rat.
    Fisher A, Biggs CS, Starr MS.
    Brain Res; 1998 May 04; 792(1):126-32. PubMed ID: 9593857
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS, Starr MS.
    Synapse; 1999 Oct 04; 34(1):36-46. PubMed ID: 10459170
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dual effects of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine independent.
    Fisher A, Biggs CS, Eradiri O, Starr MS.
    Neuroscience; 2000 Oct 04; 95(1):97-111. PubMed ID: 10619466
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats.
    El Arfani A, Bentea E, Aourz N, Ampe B, De Deurwaerdère P, Van Eeckhaut A, Massie A, Sarre S, Smolders I, Michotte Y.
    Neuropharmacology; 2014 Oct 04; 85():198-205. PubMed ID: 24863042
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Stress-induced increase in extracellular dopamine in striatum: role of glutamatergic action via N-methyl-D-aspartate receptors in substantia nigra.
    Castro SL, Zigmond MJ.
    Brain Res; 2001 May 18; 901(1-2):47-54. PubMed ID: 11368949
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats.
    Jonkers N, Sarre S, Ebinger G, Michotte Y.
    Brain Res; 2002 Feb 01; 926(1-2):149-55. PubMed ID: 11814417
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of the antiparkinsonian drug budipine on central neurotransmitter systems.
    Klockgether T, Wüllner U, Steinbach JP, Petersen V, Turski L, Löschmann PA.
    Eur J Pharmacol; 1996 Apr 22; 301(1-3):67-73. PubMed ID: 8773448
    [Abstract] [Full Text] [Related]

  • 16. In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats.
    Sarre S, Lanza M, Makovec F, Artusi R, Caselli G, Michotte Y.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):297-305. PubMed ID: 18342306
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.